Active Ingredient(s): Nitroclycerin
FDA Approved: * June 21, 2011
Pharm Company: * PROSTRAKAN INC
Category: Pain Relief

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Rectiv Overview

Dihedral at N7, N8, and N9 Thermochemistry Std enthalpy of formation (ΔfHo298) −370 kJ mol−1 Std enthalpy of combustion (ΔcHo298) −1.529 MJ mol−1 Pharmacology Legal status Routes of administration Intravenous, Oral, Sublingual, Topical, Transdermal Pharmacokinetics: Bioavailability Metabolism Hepatic Biological half-life 3 min Explosive data Shock sensitivity High Friction sensitivity High Detonation velocity 7700 m ...

Read more Rectiv Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Rectiv Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

  • Ointment: 0.4%
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Rectiv: (2 results)

Sorted by National Drug Code
  • 42747-235 Rectiv 4 mg/g Rectal Ointment by Prostrakan, Inc.
  • 58914-301 Rectiv 4 mg/g Rectal Ointment by Aptalis Pharma Us, Inc.

Other drugs which contain Nitroclycerin or a similar ingredient: (1 result)